You are here: Industry Insights > Regeneron Pharmaceuticals

News List

Regeneron's BLA for Ebola Cocktail Gets Priority Review contractpharma
April 17, 2020
VelociSuite technologies facilitate rapid generation of optimized antibodies allowing for cell line production and large-scale bioreactor manufacturing.
Regeneron identifies several antibodies against Covid-19 pharmaceutical-technology
March 19, 2020
Regeneron Pharmaceuticals has announced the identification of hundreds of fully human antibodies against Covid-19, caused by the novel coronavirus.
Kodiak Sciences preps $100M IPO to advance AMD drug fiercebiotech
September 11, 2018
Kodiak's lead asset is designed to have a longer half-life than other anti-VEGF drugs. The hope is to improve patient adherence to a treatment that is injected into the eyes.
Pfizer's Eucrisa beats Dupixent to the DTC punch in eczema, thanks to first-to-market status fiercepharma
August 24, 2017
Pfizer has already spent $2.1 million on a national TV ad for its next-gen eczema med, PDE-4 blocker Eucrisa.
Evinacumab Gets FDA Breakthrough Therapy Designation for Homozygous Familial Hypercholesterolemia americanpharmaceuticalreview
April 07, 2017
Regeneron Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation...